# MIMS Singapore vs Egydose

The clearest difference is in-app purchases: MIMS Singapore at none against Egydose's 1. MIMS Singapore also leads on iOS requirement (12.4 vs 15.6). Egydose's advantage is ratings volume (38 vs 2) and rating (4.7 vs 4.5). On price, review sentiment, update cadence and ads there is nothing between them.

Both are free to download. Egydose sells 1 one-off in-app purchase. MIMS Singapore asks for nothing beyond the download.

Egydose holds the better App Store score, 4.7 against 4.5. That said, the two scores are not equally well evidenced: Egydose has 38 ratings behind it against 2, so its average is the more settled of the two. Written reviews complicate that: 88% of MIMS Singapore's written reviews are positive against 85% of Egydose's, so the app with the better star average is not the one people write more warmly about.

MIMS Singapore ships an update every 5 weeks, Egydose every 3 weeks. The most recent releases landed on October 6, 2026 and October 4, 2026 respectively.

## The numbers

| Metric | MIMS Singapore | Egydose |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [4.5 (2 ratings)](https://appshunter.io/ios/app/mims-singapore/id623779697/reviews) | **[4.7 (38 ratings)](https://appshunter.io/ios/app/egydose/id6452034344/reviews)** |
| Number of ratings | 2 | **38** |
| Positive reviews | **87.5% of reviews** | 84.6% of reviews |
| In-app purchases | **No** | Yes |
| Ads | Yes | Yes |
| Update frequency | Every 5 weeks | **Every 3 weeks** |
| Monetization | **Ad-supported** | Free with in-app purchases |
| Size | 43 MB | 54 MB |
| Requires iOS | **12.4** | 15.6 |
| Devices | iPhone, iPad, iPod | **iPhone, iPad, iPod, Mac** |
| Age rating | 17+ | 17+ |
| Developer | [MIMS PTE. LTD.](https://appshunter.io/developer/468352272) | [MOHAMED EL GAMMAL](https://appshunter.io/developer/1710872108) |

## What reviewers say

### MIMS Singapore

[App page](https://appshunter.io/ios/app/mims-singapore/id623779697)

This medical app provides healthcare professionals with a comprehensive drug database, disease management guidelines, and the latest medical news. Access clinical information and multimedia content to support decision-making at the point of care.

**Highlights:** Drug information and interactions, Disease and condition management guidelines, Medical news and CME updates, Multimedia content with expert interviews, Concise and comprehensive drug database

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### Egydose

[App page](https://appshunter.io/ios/app/egydose/id6452034344)

This medical app assists healthcare professionals in calculating drug dosages for various patient types, including children, adults, and those with specific conditions. It provides detailed information on drug indications, administration, and compatibility, along with alternative suggestions and references.

**Highlights:** Drug dose calculation for various categories, Dose calculation for different patient types, Detailed drug information and administration, Compatibility checks (pregnancy, lactation, G6PD), Suggested drug alternatives, Includes multiple medical calculators

**Features:** Vision Pro support

**In-app purchases (1)**

| Purchase | Price | Billing |
| --- | --- | --- |
| Full Version | $14.99 | one-time |


## Frequently asked questions

### Is MIMS Singapore free?

MIMS Singapore is free to download, with no in-app purchases.

### Is Egydose free?

Egydose is free to download, with in-app purchases available.

### Which has better reviews, MIMS Singapore or Egydose?

Egydose is rated higher. MIMS Singapore averages 4.5 out of 5 from 2 ratings, while Egydose averages 4.7 from 38 ratings.

### Do MIMS Singapore or Egydose have ads?

Both MIMS Singapore and Egydose show ads.

### Which is updated more often, MIMS Singapore or Egydose?

MIMS Singapore ships an update every 5 weeks, and Egydose every 3 weeks. Most recently, MIMS Singapore was updated on October 6, 2026 and Egydose on October 4, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*